This article describes the emerging bipartisan political coalition supporting commercial competitiveness as a rationale for research and development, points to selected changes in legal and funding structures in the 1980s that stem from the success of the new political coalition and suggests some of the connections between these changes and academic science and technology, and examines the consequences of these changes for universities. The study uses longitudinal secondary data on changes in business strategies and corporate structures that made business elites (...) in the defense and health industries consider supporting competitiveness R&D policies. The article identifies and assesses an array of national R&D legislation concerned with competitiveness that was passed in the 1980s and 1990s and that has implications for academic R&D. The effects of competitiveness R&D policies on universities and academic science and technology are appraised by analyzing changes in time-series data on science and technology indicators compiled by the National Science Foundation. (shrink)

This article proposes a new bi-directional way of understanding the convergence of biology and computing. It argues for a reciprocal interaction in which biology and computing have shaped and are currently reshaping each other. In so doing, we qualify both the view of a natural marriage and of a digital shaping of biology, which are common in the literature written by scientists, STS, and communication scholars. The DNA database is at the center of this interaction. We argue that DNA databases (...) are spaces of convergence for computing and biology that change in form, meaning, and function from the 1960s to the 2000s. The first part of the article shows how, in the 1980s, DNA sequencing shifted from passively incorporating computers to be increasingly modeled in digital coding and decoding. Information retrieval algorithms, reciprocally, were altered according to the peculiarities of DNA in the first sequence-storage databases. The second part of the article investigates the impact of these reciprocal interactions and globalization on the organization of research centers, ways of conducting big science, and scientific values. Through convergence and new technologies such as data mining, biology and computing were transformed technologically, institutionally, and culturally into a new bio-data enterprise called genomics. (shrink)

Third World countries are not pursuing scientific and technological policies leading to the development of strong biotechnological industries. Their leaders have been misled into believing that modern biotechnological industries can be built in the absence of strong, intellectually aggressive, and original scientific schools. Hence, they do not strive to reform their universities, which have weak commitments to research, and do not see the importance of having research hospitals able to generate excellent and relevant clinical investigation. These strategic gaps in scientific (...) capability, the lack of governmental and corporate research funding, and the dependent nature of the chemical and pharmaceutical industries of the Third World make the development of competitive biotechnology a highly improbable event. If the present trend continues, underdeveloped countries will continue to be testing grounds for biological materials and agents, sources of valuable germplasm, and markets for high-value-added products and processes invented and manufactured in the First World. This article recommends that the international organizations collaborate in the urgent task of educating the Third World political leaders and administrators in the real problems connected with the generation of high technology. (shrink)

The significance of biotechnology in agriculture during the late twentieth century has been as much in the realm of symbol and ideology as in its political economy. The ideological roots of biotechnology are long historical ones. The ideology of “productivism,” which was codified during mid-century out of a coincidence of interest among experiment stations, USDA, Congress, agribusiness, and agricultural commodity groups, has encountered numerous challenges since the 1970s. One of the major responses to the crisis of productionism was to forge (...) a social definition of biotechnology as being a revolutionary technology. I conclude by discussing whether biotechnology, as both symbol and substance, is likely to be a basis for attempts to resuscitate productivism in the 1990s now that biotechnology is being demystified, its limits being appreciated, and its opposition still considerable. (shrink)

Organizational institutionalism has shown how institutional entrepreneurs can introduce new logics into fields and push for their broader acceptance. In academic science in the United States, however, market logic gained strength without such an entrepreneurial project. This article proposes an alternative “practice selection” model to explain how a new institutional logic can gain strength when local innovations interact with changes outside the field. Actors within a field are always experimenting with practices grounded in a variety of logics. When one logic (...) is dominant, innovations based on alternative logics may have trouble gaining the resources they need to become more broadly institutionalized. But if a changing environment starts systematically to favor practices based on an alternative logic, that logic can become stronger even in the absence of a coherent project to promote it. This is what happened in US academic science, as growing political concern with the economic impact of innovation changed the field’s environment in ways that encouraged the spread of local market-logic practices. (shrink)

Starting from the sixties of the past century theory change has become a main concern of philosophy of science. Two of the best known formal accounts of theory change are the post-Popperian theories of verisimilitude (PPV for short) and the AGM theory of belief change (AGM for short). In this paper, we will investigate the conceptual relations between PPV and AGM and, in particular, we will ask whether the AGM rules for theory change are effective means for approaching the truth, (...) i.e., for achieving the cognitive aim of science pointed out by PPV. First, the key ideas of PPV and AGM and their application to a particular kind of propositional theories - the so called "conjunctive propositions" - will be illustrated. Afterwards, we will prove that, as far as conjunctive propositions are concerned, AGM belief change is an effective tool for approaching the truth. (shrink)

This article examines the ethical dilemmas that can occur due to university and industry cooperative arrangements. The values that Conant (1952) and Merton (1942) ascribed to university science are used as a measure of the evolving university-industry relations in the 1980s. Examples of the types of relations being forged are discussed and possible conflicts of interest are explored. The author argues that the goals of the university are and must remain different from those of industry for the good of the (...) entire society. The transformation of the university into a research institution for industry could result in the university not adequately training the scientists of tomorrow, and simultaneously, not discharging its duty to do basic research as it focuses on the more applied research that industry desires and funds. (shrink)

This article examines some of the controversial issues emerging from the privatization of biomedical research and commercialization of biotechnology. The aim is to identify the dominant social, political, and ethical risks associated with the recent shift from academic to corporate science and from the increasing emphasis on investing in research projects that will result in the award of a monopoly patent. Identifying these risks may ultimately assist policy makers in designing new policies or reforming existing practices that will come closer (...) to achieving an equitable balance between science pursued for the advance of knowledge and science pursued for patents and profit. The discussion may also assist the research directors or managers of biopharmaceutical companies in designing corporate policies that will optimize the balance between the serendipity of scientific discovery and the discipline of strategic business planning. (shrink)

Availability of external funding influences the viability and structure of scientific fields. In the 1980s, structural changes in the manner in which external funds became available started to have an impact on materials science and engineering in the United States. These changes colluded with the search for a disciplinary identity of this research field inside the university. The solutions that arose were intended to find a mediating structure between external demands and resources and disciplinary orientation. Interviews with seventeen scientists in (...) seven universities revealed the impact in local university settings. The rise of research centers as new organizational units in universities can be linked to two periods. In the 1960s, expensive instruments stimulated unit formation; in the 1980s, the increase in application-related funding forced new administrative ways. It is shown that organizational changes also have an impact on disciplinary identity as witnessed by a strong increase in interdisciplinary materials Ph.D.s awarded. (shrink)

Third World countries are not pursuing scientific and technological policies leading to the development of strong biotechnological industries. Their leaders have been misled into believing that modern biotechnological industries can be built in the absence of strong, intellectually aggressive, and original scientific schools. Hence, they do not strive to reform their universities, which have weak commitments to research, and do not see the importance of having research hospitals able to generate excellent and relevant clinical investigation. These strategic gaps in scientific (...) capability, the lack of governmental and corporate research funding, and the dependent nature of the chemical and pharmaceutical industries of the Third World make the development of competitive biotechnology a highly improbable event. If the present trend continues, underdeveloped countries will continue to be testing grounds for biological materials and agents, sources of valuable germplasm, and markets for high-value-added products and processes invented and manufactured in the First World. This article recommends that the international organizations collaborate in the urgent task of educating the Third World political leaders and administrators in the real problems connected with the generation of high technology. (shrink)

Disclosure of financial interests in scientific research is the centerpiece of the new conflict of interest regulations issued by the U.S. Public Health Service and the National Science Foundation that became effective October 1, 1995. Several scientific journals have also established financial disclosure requirements for contributors. This paper measures the frequency of selected financial interests held among authors of certain types of scientific publications and assesses disclosure practices of authors. We examined 1105 university authors (first and last cited) from Massachusetts (...) institutions whose 789 articles, published in 1992, appeared in 14 scientific and medical journals. (shrink)

Essay Review: Medicine To Make You Mad Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America by Robert Whitaker Henry H. Bauer Essay Review: Apparitions of the Living: The Views of William H. Harrison and Gabriel Delanne Spirits Before Our Eyes by William H. Harrison Les Apparitions Matérialisées des Vivants & des Morts. Vol. 1: Les Fantômes de Vivants [Materialized Apparitions of the Living and of the Dead. Vol. 1: Phantoms of the (...) Living] by Gabriel Delanne Carlos S. Alvarado Phantasms of the Living by Edmund Gurney, Frederic W. H. Myers, and Frank Podmore Bryan J. Williams Nonsense on Stilts: How To Tell Science from Bunk by Massimo Pigliucci Constantin Cranganu Nonsense on Stilts: How To Tell Science from Bunk by Massimo Pigliucci Hannah Jenkins The Logical Leap: Induction in Physics by David Harriman Michael Davidson Paranormal America: Ghost Encounters, UFO Sightings, Bigfoot Hunts, and Other Curiosities in Religion and Culture by Christopher D. Bader, F. Carson Mencken, and Joseph O. Baker Mark Rodeghier Loch Ness, Nessie, & Me: The Truth Revealed by Tony Harmsworth Karl P. N. Shuker Conscious Connections: About Parapsychology and Holistic Biology by Göran Brusewitz Michael Nahm Science & Spirit by Hernani Guimarães Andrade Wellington Zangari & Fatima Regina Machado The Sixth Sense Reader edited by David Howes Patric Giesler. (shrink)

Tacit knowledge is widely acknowledged to be an important component of innovation, but such recognition is rarely accompanied by more detailed explanations about the nature of tacit knowledge, why such knowledge is significant, how it becomes codified or whether there may be limits to codification. This paper attempts to fill some of the gaps, drawing on a recent study of university/industry links in three emerging technologies. It concludes that tacit knowledge, which can only be transmitted through personal interaction, will continue (...) to play an important role in innovation. This derives from a variety of reasons, but most significant are the complexity of systems and the emergence of new technologies. (shrink)

The rapid, recent emergence of new medical knowledge models has engendered a dizzying number of new medical initiatives, programs and approaches. Fields such as evidence-based medicine and translational medicine all promise a renewed relationship between knowledge and medicine. The question for philosophy and other fields has been whether these new models actually achieve their promises to bring about better kinds of medical knowledge—a question that compels scholars to analyze each model’s epistemic claims. Yet, these analyses may miss critical components that (...) explain how these models actually work and function. Using the case of translational medicine, this paper suggests that analyses which treat these models as a primarily epistemic interventions miss the way that new approaches are increasingly shaped by specific financial and commercial agendas. Ultimately, social epistemological analyses that are attentive to market forces are required to make sense of emerging bioscientific research models, which are increasingly tethered to or a manifestation of increasingly financialized models of science research and innovation. (shrink)

All biotechnology-related promises are based upon its technological potential; yet, many of these promises assure the solution for chronic socio-economic problems in the Third World through a new technological revolution in agriculture. The forecasting is that such a revolution will start delivering its most profound impact early in the 21st century. However, 11 years before the year 2000, a critical analysis of its promises against its current trends indicates that the future use and impact of biotechnology in the Third World (...) rely presently upon crucial contradictions.As a result of such contradictions—Social Goals vs. Private Gains, Social Problems vs. Technical Solutions, Agricultural vs. Industrial Revolution, Cooperation vs. Competition, and Control over Nature vs. Control Over People—there is a high likelihood that (1) traditional farming will become increasingly obsolete, (2) technological and economic dependence of developing on developed countries will persist and even increase, (3) food and fiber production will be increasingly dislocated from developing to developed countries and from farms to industries, (4) the market for specific tropical products will be destroyed and therefore entire economies may collapse, (5) hunger and poverty will persist and even increase, and (6) social unrest may increase worldwide. (shrink)

The predominant position of large companies, while crucial for the acceptance of biotechnology, at the same time slows down the pace of biotechnological development and application. Large agrochemical and food processing companies are characterized by a number of internal barriers against applications of biotechnology in agriculture. They also show a greater sensibility to the external barriers than many small companies. Their takeover of agricultural biotechnology, therefore, has led to a more evolutionary than revolutionary development.

This paper reviews current trends in the development of agricultural biotechnology, including (1) the recent and potential biotechnology products and processes in the plant, animal and food sciences, and (2) the enormous increase in Federal and State government and industrial investments in biotechnology research. Next we analyze the impacts and possible consequences of agricultural biotechnology for public and private agricultural research and for the structure and nature of the food system in this country and around the world. We conclude with (...) a range of proposals for agricultural research policies. Among the possible consequences we discuss are: (1) a shift in disciplinary emphasis in the research community to molecular biology, (2) reduction of research on systems, ecology, and the social sciences, (3) increased concentration of research funds at a small number of institutions, (4) reduction of long-term research in the public sector, (5) increased collaboration between industry, government and universities with a restriction of scientific communication, and a potential for conflict of interest, favoritism and increased scientific misconduct, (6) a change of the primary goals and agenda of the public sector research community, and (7) increased concentration in the agribusiness sector and the industrialization of the food system. Our policy suggestions include: (1) maintaining and strengthening an independent public research and teaching system, (2) striking a balance between short-term proprietary biotechnology and long-term nonproprietary research, (3) maintaining an extension system that delivers biotechnology information and products to all potential users, (4) developing a regulatory system that adequately protects the public and provides clear guidelines to industry. (5) assisting developing nations to reap the benefits of the biotechnology revolution, and (6) establishing mechanisms to foster broad-based understanding of the social and ethical issues relating to agricultural biotechnology and to promote research on the social and ethical impacts. (shrink)

The Argumentwhile reconizing that public sector research has long been managed by a wide variety of practices and techniques, this paper concentrates on the increasingly important role that patents are playing in the management and regulation of public sector research. It argues that as a specific form of technology, patents play a significant and growing role in facilitating the management of the scientific object and can also be seen as a particular instance of governmentality. More specifically, it argues that patents (...) have had an important impact on the culture and political ecomomy of science. In this sence patents can be seen not only as a legal regime that provides limited property rights over technical information but also as a sophisticated tool of discipline and control that is used to regulate and manage public sector research. The paper suggests that with the increasing use of patents as a means of governing science, we are witnessing the growing juridification of science, the intervention of the law into an arena it hitherto largely ignored. (shrink)

The past twenty years have been an incredibly productive period in science studies. Still, because recent work in science studies puts a spotlight on agency and enabling situa tions, many practitioners in the field ignore, underplay, or dismiss the possibility that historically established, structurally stable attributes of the world may systemically shape practice at the laboratory level. This article questions this general position. Draw ing on data from a participant observation study of a university biology laboratory, it describes five features (...) of the institutional landscape that shape this laboratory's practice. (shrink)

Following in the footsteps of a variety of previous research that elaborates on the current state of affairs in academia, this article sets out the argument that neoliberalism and its corresponding iterations of science and technology and research funding policies in this country have implications for the types of knowledge that can be generated within and communicated without contemporary institutions of higher education. Using agricultural biotechnology as the lens through which to focus analysis, the article outlines a number of empirical (...) examples that illustrate how the free flow of knowledge either critical of or not readily appropriated by capital is being impeded. (shrink)

The history of the controversy overrecombinant bovine growth hormone (rBGH) is exploredin terms of the issue of the potential robustness ofa consumption-driven ``new'' politics of food andagriculture. It is noted that while the dominanthistorical traditions in the social sciences haveserved to discount the autonomous role that consumersand consumption play in modern societies, there hasbeen growing interest in consumption within foodstudies as well as other bodies of scholarship such aspostmodernism, social constructivism, socialcapital/social distinction, and environmentalsociology. A review of the shifting pattern (...) ofdiscourses during the rBGH controversy shows thatconsumption-driven claims and politics played atangible, but relatively minor role. Even so, it issuggested that the rBGH experience along with paralleltrends in food politics (e.g., anti-pesticidecampaigns such as the ``Alar scare,'' agribusinessattempts to intimidate opponents through fooddisparagement laws, conditions-of-productionprovisions of the World Trade Organization agreement)could make the consumption/consumer dimension of foodpolitics more important in the future. (shrink)

Despite its use to exemplify how the world is “flat,” India is in many ways “spiky.” Hyderabad is a prosperous hub of information–communication technology while its impoverished agricultural hinterland is best known for dysfunctional agriculture and farmer suicide. Based on the belief that a lack of knowledge and skill lay at the root of agrarian distress, the “e-Sagu” project aimed to leverage the city’s scientific expertise and ICT capability to aid cotton farmers. The project fit with a national surge of (...) “last mile” projects bringing ICT to the village, but it was unique in using ICT to connect farmers directly with agricultural scientists acting as advisors. Such projects fit the interests of many actors, which has led to an unrealistic national enthusiasm about their impacts. This article uses the first five years of the project as a lens to view the cultural nature of both indigenous agricultural knowledge and “scientific” agricultural advising. Unlike lay publics whose uptake of science is better known, with farmers the invention and adoption of agro-scientific knowledge is deeply embedded in daily productive activities and sociocultural interactions. E-Sagu eventually had to abandon its construction of agricultural science as objective and acultural, resorting to rural methods of persuasion. It also found that it could only survive by joining forces with companies promoting commodification of agricultural inputs, which was a cause of the agrarian distress it sought to alleviate. (shrink)

The existing literature on the development of recombinant DNA technology and genetic engineering tends to focus on Stanley Cohen and Herbert Boyer's recombinant DNA cloning technology and its commercialization starting in the mid-1970s. Historians of science, however, have pointedly noted that experimental procedures for making recombinant DNA molecules were initially developed by Stanford biochemist Paul Berg and his colleagues, Peter Lobban and A. Dale Kaiser in the early 1970s. This paper, recognizing the uneasy disjuncture between scientific authorship and legal invention (...) in the history of recombinant DNA technology, investigates the development of recombinant DNA technology in its full scientific context. I do so by focusing on Stanford biochemist Berg's research on the genetic regulation of higher organisms. As I hope to demonstrate, Berg's new venture reflected a mass migration of biomedical researchers as they shifted from studying prokaryotic organisms like bacteria to studying eukaryotic organisms like mammalian and human cells. It was out of this boundary crossing from prokaryotic to eukaryotic systems through virus model systems that recombinant DNA technology and other significant new research techniques and agendas emerged. Indeed, in their attempt to reconstitute 'life' as a research technology, Stanford biochemists' recombinant DNA research recast genes as a sequence that could be rewritten thorough biochemical operations. The last part of this paper shifts focus from recombinant DNA technology's academic origins to its transformation into a genetic engineering technology by examining the wide range of experimental hybridizations which occurred as techniques and knowledge circulated between Stanford biochemists and the Bay Area's experimentalists. Situating their interchange in a dense research network based at Stanford's biochemistry department, this paper helps to revise the canonized history of genetic engineering's origins that emerged during the patenting of Cohen-Boyer's recombinant DNA cloning procedures. (shrink)

The rapid commercialization of applied genetics in the mtd-1970s, accompanied by a sudden rise in academic-corporate partnerships, raised questions about the impacts these linkages have had on the social and professional norms of scientists. The extent and pattern of faculty tnvolvement in commercialization of biological research is largely an unexplored area. This article provcdes a quantitative assessment of the linkages between biology faculty in American uncverscties and the newly formed biotechnology industry. The results of thes study, covering the period 1985-88, (...) show that academic scientists responded en masse to participating in the commercialization of genetecs research by estabhshmg formal associations with many of the new biotechnology compances. A data base consisting of 889 U.S. and Canadian biotechnology companies and 832 sccentcsts who had formal ties to them was developed over a four-year period. The patterns of academic-corporate Icnkages are revealed by institution. Three universities with the most commercially active faculty are Harvard, Stanford, and MIT. Of the 359 bcomedeca! scientists and geneteccsts who were members of the Nateonal Academy of Sceences, at minimum, 37% had formal ties with the biotechnology industry. (shrink)

Is Translational Science and Medicine new? Its dramatic expansion has spelled a dizzying array of new disciplines, departments, buildings, and terminology. Yet, without novel theories or concepts, Translational Science and Medicine may appear to be nothing more than an old concept with a new brand. Yet, is this view true? As is illustrated herein, histories of TSM which treat it as merely an old product under a new name misunderstand its essential architecture. As an expressly economic transformation, modern translational approaches (...) are differentiated precisely by a set of semi-permanent architectures which render it an altogether different kind of object when compared to previous attempts by institutions to turn science into medicine. Powered by new software, embedded within campuses that now house companies, and with legal agreements that outline agreed-upon scientific activity, TSM is now powered by a set of robust and durable structures that differentiate it from previous approaches. Based on ethnographic research about translational neuroscience in North America, this paper suggests that the sense of TSM as not being new is a consequence of analytic modes that tend to see scientific enterprises in epistemic terms alone. Analyzing TSM as primarily a scientific object misses the fact that it is a principally a financial one. (shrink)

Scientists continually face public concerns over the potential risks of biotechnology. This article reflects on the 1970s when leading molecular biologists established a moratorium, and initiated the second international Asilomar conference, on recombinant DNA molecules. Since then, this event has been widely perceived as an important historical moment when scientific actors took into account public concerns. Yet, by focusing on the history of the Public Understanding of Science discourse, we gain new insight into how ‘‘science’’ and the ‘‘public’’ have in (...) the meantime been framed in political discourses as homogeneous but antagonistic concepts. This sheds new light on the ways scientific, political, and administrative actors in biotechnology perceive the events, which occurred in the 1970s. Through interviews, we found that, with the Asilomar II conference serving as a quasi role model, the quest to reconcile ‘‘science’’ and the ‘‘public’’ is being traced back to a moment in history when such divisions had yet to be considered. This leads us to ask whether the politics of PUS contributed as much to the production of these two entities as it is claimed to have done in bridging the differences between them. (shrink)

The growing role of universities in the knowledge economy as well as technology transfer has increasingly been conceptualized in terms of the hybridization of public academic work and private business activity. In this article, we examine the difficulties and prospects of this kind of intermingling by studying the long-term trajectories of two research groups operating in the fields of plant biotechnology and language technology. In both cases, the attempts to simultaneously pursue academic and commercial activities led to complicated boundary maintenance, (...) which arose from the conflicting procedures and requirements of the two activities as well as from the double roles assumed by the actors involved. We, thus, argue that the construction of boundaries is not as contingent and strategic as has often been assumed but is built, instead, on the characteristic goals and tasks of the activities in question. Moreover, we suggest that the discussion on university—industry relationships and the entrepreneurial university has by and large neglected the fact that most universities are either public sector entities or tax-exempt organizations thereby being subject to strict rules and regulations that govern the ways in which they may become engaged in commercial activities. Furthermore, several other enduring cultural features, such as the university’s commitment to open scholarly communication, make the boundary between university and commerce relatively stable. As a consequence, the results of this study lend support to the thesis according to which boundaries in science are not always created at will but reflect the long history and multifaceted societal relevance of this particular institution. This in turn implies that the commodification of university research is bound to be more difficult than what the proponents of the entrepreneurial university seem to assume. (shrink)

Hybrid scientific fields consist of a collection of knowledge-producing and -utilising organisations, fulfilling a dual role of providing specific knowledge services as well as contributing to increased scientific understanding. In this article, the processes that govern scientific knowledge production in hybrid scientific fields are explored. While such sets of organisations are targeted in science policy as receivers of resources, as well as providers of services and other knowledge products, attention in science studies is all but lacking. Data from a study (...) on toxicology as a representative of public health sciences are used. The author will focus on the effects on scientific research and its organisational relations by discussing three social processes relevant to knowledge production, problem choice, resource distribution, and reputational control. (shrink)

Third World countries are not pursuing scientific and technological policies leading to the development of strong biotechnological industries. Their leaders have been misled into believing that modern biotechnological industries can be built in the absence of strong, intellectually aggressive, and original scientific schools. Hence, they do not strive to reform their universities, which have weak commitments to research, and do not see the importance of having research hospitals able to generate excellent and relevant clinical investigation. These strategic gaps in scientific (...) capability, the lack of governmental and corporate research funding, and the dependent nature of the chemical and pharmaceutical industries of the Third World make the development of competitive biotechnology a highly improbable event. If the present trend continues, underdeveloped countries will continue to be testing grounds for biological materials and agents, sources of valuable germplasm, and markets for high-value-added products and processes invented and manufactured in the First World. This article recommends that the international organizations collaborate in the urgent task of educating the Third World political leaders and administrators in the real problems connected with the generation of high technology. (shrink)

Based on data from a survey of biological scientists at 125 American universities, this article explores how the commercialization of the university affects the problems academic scientists pursue and argues that this reorientation of scientific agendas results in a shift from science in the public interest to science for private goods. Drawing on perspectives from Bourdieu on how actors employ strategic practices toward the accumulation of social capital and acquire dispositional and perceptional tendencies that in turn recondition social structures, the (...) commercialization of the university is construed not as something that ‘‘happens to,’’ but rather something that ‘‘happens through’’ academic scientists. The specific shape and direction of the commercialization of the university is therefore influenced by how scientists incorporate the new resources and social relations of commercialization into their scientific practice and how their creative engagement with shifting structural conditions remakes the culture of academic science. (shrink)

This article focuses on a crucial development in genetic research that occurred in the 1990s: the identification of the first two of the genes responsible for hereditary breast and ovarian cancer. Issues addressed touch on the evolution of the subfield, its potential impact on cancer treatment, and industry involvement. The article follows the activities of the various research groups competing in the race to identify the genes and depicts the frequent conflicts between them. Data are derived chiefly from a bibliometric (...) database. The results show a diversity of research practices. Industrial researchers interacted within far more tightly knit networks than their counterparts working in public organizations. The patenting and commercial exploitation of results led to fierce battles, with one group capturing most of the benefits. (shrink)

This paper explores the increasing trend towards the commodification of public research and development (R&D) and the impact of this on social wellbeing. In many developed countries, the changes introduced by governments to funding mechanisms for universities and public research institutions has led to a fundamental shift in the focus of public R&D. The focus has shifted from creating useful public, codifiable knowledge to creating a knowledge commodity driven by commercial imperatives. Although there may be an economic argument to be (...) made for the virtues of such change, we argue here that the potential costs to social wellbeing have been largely, and dangerously, ignored. (shrink)